Analyst Activity – Oppenheimer Reiterates Buy on Intec Pharma (NASDAQ:NTEC)

ME Staff
-
0

Analyst Ratings For Intec Pharma (NASDAQ:NTEC)

Today, Oppenheimer reiterated its Buy rating on Intec Pharma (NASDAQ:NTEC).

Some recent analyst ratings include

  • 3/21/2018-Oppenheimer Reiterated Rating of Buy.
  • 2/28/2018-Ladenburg Thalmann Financial Services initiated coverage with a Buy rating.
  • 9/21/2017-CIBC Reiterated Rating of Outperform .


    Recent Trading Activity for Intec Pharma (NASDAQ:NTEC)
    Shares of Intec Pharma closed the previous trading session at 6.30 +0.00 0.00% with 6.25 shares trading hands.